AEON Biopharma Inc

Contributing Author

Recent Articles by AEON Biopharma Inc

Apr-03	AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 AEON GlobeNewswire
Apr-03	AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards AEON GlobeNewswire
Mar-30	AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program AEON -14.70% GlobeNewswire
Mar-25	AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program AEON GlobeNewswire
Mar-09	AEON Biopharma Appoints John Bencich as Chief Financial Officer AEON +7.48% AEON GlobeNewswire
Mar-05	AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting AEON -5.50% GlobeNewswire
Jan-21	AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions AEON -13.97% AEON +13.33% GlobeNewswire
Dec-19	AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 AEON +6.93% GlobeNewswire
Dec-15	AEON Biopharma Announces Execution of Exchange Agreement with Daewoong AEON +19.21% AEON +5.10% GlobeNewswire
Nov-20	AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling AEON -12.79% GlobeNewswire
Nov-14	AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth AEON GlobeNewswire